Patents by Inventor Junping Kou

Junping Kou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of isolating sphingolipids from cordyceps and their use
    Patent number: 11357806
    Abstract: A method of isolating at least one sphingolipid portion selected from a sphingoid base portion, a ceramide portion, a glycosphingolipid portion or a phosphosphingolipid portion from Cordyceps, in particular from wild-type Cordyceps, allows for obtaining sphingolipid portions having an increased amount of one of sphingoid bases, ceramides, glycosphingolipids or phosphosphingolipids. The sphingolipid portions isolated contained significant amounts of sphingolipids not reported so far, and possess exceptional immunosuppressive activities. A method of treating a subject suffering from an inflammatory disease like an autoimmune disease or an allergic disease includes administering sphingolipids isolated from Cordyceps, in particular from wild-type Cordyceps. A method of treating a subject suffering from an inflammatory disease includes administering certain sphingolipids to the subject.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: June 14, 2022
    Assignee: Macau University of Science and Technology
    Inventors: Zhi-Hong Jiang, Jing-Rong Wang, Jia-Ning Mi, Junping Kou, Yuwei Han, Yingqiong Xu
  • METHOD OF ISOLATING SPHINGOLIPIDS FROM CORDYCEPS AND THEIR USE
    Publication number: 20170128507
    Abstract: A method of isolating at least one sphingolipid portion selected from a sphingoid base portion, a ceramide portion, a glycosphingolipid portion or a phosphosphingolipid portion from Cordyceps, in particular from wild-type Cordyceps, allows for obtaining sphingolipid portions having an increased amount of one of sphingoid bases, ceramides, glycosphingolipids or phosphosphingolipids. The sphingolipid portions isolated contained significant amounts of sphingolipids not reported so far, and possess exceptional immunosuppressive activities. A method of treating a subject suffering from an inflammatory disease like an autoimmune disease or an allergic disease includes administering sphingolipids isolated from Cordyceps, in particular from wild-type Cordyceps. A method of treating a subject suffering from an inflammatory disease includes administering certain sphingolipids to the subject.
    Type: Application
    Filed: April 18, 2016
    Publication date: May 11, 2017
    Inventors: Zhi-Hong Jiang, Jing-Rong Wang, Jia-Ning Mi, Junping Kou, Yuwei Han, Yingqiong Xu